Weinberg Andrew D, Evans Dean E, Thalhofer Colin, Shi Tom, Prell Rodney A
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, 4805 N.E. Glisan, Portland, OR 97213, USA.
J Leukoc Biol. 2004 Jun;75(6):962-72. doi: 10.1189/jlb.1103586. Epub 2004 Mar 2.
OX40 (CD134), a membrane-bound member of the tumor necrosis factor-receptor superfamily, is expressed primarily on activated CD4(+) T cells. Following engagement on the cell surface, OX40 delivers a costimulatory signal that leads to potent, proinflammatory effects. Engagement of OX40 during antigen (Ag)-specific stimulation of T cells leads to increased production of memory T cells, increased migration of Ag-specific T cells, enhanced cytokine production by effector T cells, and the ability to break peripheral T cell tolerance in vivo. Therefore, OX40 engagement in vivo could have important ramifications for the enhancement of vaccine strategies and inhibition of unwanted inflammation. This review summarizes the molecular and cellular events that occur following OX40 engagement during Ag-specific T cell activation.
OX40(CD134)是肿瘤坏死因子受体超家族的膜结合成员,主要表达于活化的CD4(+) T细胞上。在细胞表面结合后,OX40传递共刺激信号,导致强大的促炎效应。在T细胞的抗原(Ag)特异性刺激过程中,OX40的结合导致记忆T细胞产量增加、Ag特异性T细胞迁移增加、效应T细胞细胞因子产生增强,以及在体内打破外周T细胞耐受性的能力。因此,体内OX40的结合可能对增强疫苗策略和抑制不必要的炎症具有重要影响。本综述总结了在Ag特异性T细胞活化过程中OX40结合后发生的分子和细胞事件。